Become a Member

Baxter International Inc. (BAX)

Healthcare • Medical - Instruments & Supplies

48
Beobachten
$22,01
Price
+6,12%
Change
11,32 Mrd. $
Market Cap
-
P/E Ratio

Neumann-Score Stock Analysis

48
out of 100
Beobachten
Valuation??/100
Profitability??/100
Growth??/100

Unlock Score Details

Become a member and get access to all analyses.

Become a Member

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, c ...

CEO
Andrew Hider
Employees
38.000
Country
US